P000368
Should 21-hydroxylase deficiency genotyping be considered in assisted reproductive technology programs?
Courtesy of the U.S. National Library of Medicine. This snapshot may differ from current PubMed records. NLM does not endorse this site.
- Topic
- 21-hydroxylase deficiency (21OHD); Congenital adrenal hyperplasia (CAH)
- Gene
- CYP21A2
Cite this resource
DSD Research Library | Should 21-hydroxylase deficiency genotyping be considered in assisted reproductive technology programs? | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/papers/P000368?version=v1.4.0